www.fdanews.com/articles/108587-allergan-closes-purchase-of-aczone-gel-for-150-million
Allergan Closes Purchase of Aczone Gel for $150 Million
July 15, 2008
Allergan’s wholly owned subsidiary, Allergan Sales, LLC, announced the completion of acquisition of Aczone Gel 5% product of QLT USA, Inc., a wholly owned subsidiary of QLT Inc. Aczone Gel 5% product is a topical treatment for acne vulgaris.
RTTNews
RTTNews